Effects of Cistanche Deserticola Supplementation on Anaerobic Exercise Performance and Recovery in Men
Summary
A double-blind, randomized, placebo-controlled clinical trial has been registered to evaluate whether 8 weeks of Cistanche deserticola supplementation combined with standardized anaerobic training improves exercise performance, recovery markers, and body composition in young adult men across different athletic training levels. Participants will be assigned to receive either Cistanche deserticola extract or matched placebo while completing the same supervised training protocol, with outcomes assessed via Wingate tests, jump performance, blood lactate, creatine kinase, and hormonal indicators.
“This study is a double-blind, randomized, placebo-controlled trial designed to examine whether 8 weeks of Cistanche deserticola supplementation, when combined with a standardized anaerobic training program, can improve anaerobic exercise performance, recovery, and selected body composition outcomes in young adult men with different athletic training levels.”
About this source
GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 686 changes logged to date.
What changed
A new clinical trial registration has been added to ClinicalTrials.gov under identifier NCT07546513. The trial will enroll participants to receive either Cistanche deserticola extract or a matched placebo while completing standardized anaerobic training over 8 weeks, with primary endpoints including Wingate test outcomes, jump performance, and recovery-related blood biomarkers.
Affected parties include contract research organizations, institutional review boards overseeing human subjects research, and manufacturers of Cistanche-based supplements. Researchers conducting athletic performance or dietary supplement trials should monitor this study's outcomes for implications on evidence standards for ergogenic aids.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Effects of Cistanche Supplementation on Anaerobic Exercise Performance and Recovery in Men With Different Athletic Training Levels
N/A NCT07546513 Kind: NA Apr 22, 2026
Abstract
This study is a double-blind, randomized, placebo-controlled trial designed to examine whether 8 weeks of Cistanche deserticola supplementation, when combined with a standardized anaerobic training program, can improve anaerobic exercise performance, recovery, and selected body composition outcomes in young adult men with different athletic training levels.
Participants will be assigned to receive either Cistanche deserticola extract or a matched placebo while completing the same supervised anaerobic training program. The study will assess changes in anaerobic performance, including Wingate test outcomes and jump performance, as well as recovery-related indicators such as blood lactate, creatine kinase, malondialdehyde, testosterone, cortisol, and the testosterone-to-cortisol ratio. Body composition outcomes, including body fat percentage and skeletal muscle mass, will also be evaluated.
The purpose of this study is to determine whether Cistanche deserticola supplementation provides additional benefits beyond training alone, and whether these effects differ between highly trained and recreationally trained participants.
Conditions: Athlete, Elite Athlete, Sport Performance, Exercise Recovery
Interventions: Cistanche deserticola, Matched placebo paste, Standardized anaerobic training program
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.